NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?. (12th May 2016)
- Record Type:
- Journal Article
- Title:
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?. (12th May 2016)
- Main Title:
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- Authors:
- Cantoni, Claudia
Huergo-Zapico, Leticia
Parodi, Monica
Pedrazzi, Marco
Mingari, Maria Cristina
Moretta, Alessandro
Sparatore, Bianca
Gonzalez, Segundo
Olive, Daniel
Bottino, Cristina
Castriconi, Roberta
Vitale, Massimo - Other Names:
- Berzins Stuart Academic Editor.
- Abstract:
- Abstract : Several evidences suggest that NK cells can patrol the body and eliminate tumors in their initial phases but may hardly control established solid tumors. Multiple factors, including the transition of tumor cells towards a proinvasive/prometastatic phenotype, the immunosuppressive effect of the tumor microenvironment, and the tumor structure complexity, may account for limited NK cell efficacy. Several putative mechanisms of NK cell suppression have been defined in these last years; conversely, the cross talk between NK cells and tumor cells undergoing different transitional phases remains poorly explored. Nevertheless, recent in vitro studies and immunohistochemical analyses on tumor biopsies suggest that NK cells could not only kill tumor cells but also influence their evolution. Indeed, NK cells may induce tumor cells to change the expression of HLA-I, PD-L1, or NKG2D-L and modulate their susceptibility to the immune response. Moreover, NK cells may be preferentially located in the borders of tumor masses, where, indeed, tumor cells can undergo Epithelial-to-Mesenchymal Transition (EMT) acquiring prometastatic phenotype. Finally, the recently highlighted role of HMGB1 both in EMT and in amplifying the recruitment of NK cells provides further hints on a possible effect of NK cells on tumor progression and fosters new studies on this issue.
- Is Part Of:
- Journal of immunology research. Volume 2016(2016)
- Journal:
- Journal of immunology research
- Issue:
- Volume 2016(2016)
- Issue Display:
- Volume 2016, Issue 2016 (2016)
- Year:
- 2016
- Volume:
- 2016
- Issue:
- 2016
- Issue Sort Value:
- 2016-2016-2016-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-05-12
- Subjects:
- Immunology -- Periodicals
Immunology -- Research -- Periodicals
616.07905 - Journal URLs:
- https://www.hindawi.com/journals/jir/ ↗
- DOI:
- 10.1155/2016/4684268 ↗
- Languages:
- English
- ISSNs:
- 2314-8861
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 22828.xml